GTCR Recapitalizes PathGroup
May 13, 2022
GTCR has made a majority investment in PathGroup Holdings LLC in a recapitalization that leaves founder and CEO Dr. Ben Davis and the PathGroup management team substantially reinvested. Pritzker Private Capital and Vesey Street Capital Partners will retain minority stakes; the investment will fund geographic expansion (including into Texas), capability building across pathology, molecular and genetic diagnostics, and strategic M&A, and names Dave King as board chairman.
- Buyers
- GTCR
- Targets
- PathGroup Holdings LLC
- Sellers
- Pritzker Private Capital, Vesey Street Capital Partners
- Industry
- Healthcare Services
- Location
- Tennessee, United States
- Transaction Type
- Recapitalization
Explore More
Related Acquisitions
-
PathGroup Acquires Pathology Consultants in Greenville, SC
January 24, 2022
Healthcare Services
PathGroup, a PE-backed provider of anatomic, clinical, molecular and digital pathology services, has acquired Pathology Consultants, a Greenville, South Carolina-based pathology services provider. The acquisition expands PathGroup’s service capabilities and geographic footprint across the Southeastern United States and adds clinical and molecular services to Pathology Consultants’ existing hospital and physician clients.
-
PathGroup Acquires SkinDx
June 16, 2021
Healthcare Services
PathGroup, a Pritzker Private Capital‑backed pathology services provider based in Nashville, Tenn., has acquired SkinDx, a dermatopathology laboratory headquartered in Birmingham, Alabama. The transaction expands PathGroup’s dermatopathology capabilities and regional presence across the Southeast, Midwest and Mid‑Atlantic, and brings SkinDx access to PathGroup’s molecular and clinical pathology services.
-
PathGroup Acquires DermLab
August 30, 2021
Healthcare Services
PathGroup, a leading provider of anatomic, clinical, molecular and digital pathology services, has acquired DermLab, an independent dermatopathology laboratory based in Birmingham, Alabama. The acquisition expands PathGroup's dermatopathology capabilities and strengthens its presence in the Southeastern United States as an add-on to its existing portfolio.
-
Kohlberg & Company Recapitalizes Trinity Life Sciences
November 30, 2021
Healthcare Services
Kohlberg & Company will recapitalize Trinity Life Sciences, replacing Parthenon Capital as the company’s capital partner. The transaction provides Trinity with new growth capital to support global expansion, technology and data-driven capability investments while Trinity’s management team, led by CEO David Fitzhenry, will remain in place.
-
Iron Path Capital Recapitalizes Capitol Pain Institute
June 23, 2022
Healthcare Services
Iron Path Capital has recapitalized an affiliate of Capitol Pain Institute (CPI), a physician-led interventional pain management provider that was previously a portfolio company of New State Capital Partners. The recapitalization will support CPI as a platform to expand nationally—affiliating with independent pain practices and building de novo clinics and ambulatory surgical centers across the West and Midwest; terms were not disclosed.
-
StageBio Acquires TPL Path Labs
October 21, 2020
Healthcare Services
StageBio, a portfolio company of Ampersand Capital Partners, has acquired TPL Path Labs of Freiburg, Germany, expanding its GLP/GCLP-compliant preclinical and clinical histopathology and molecular pathology capabilities in Europe. The deal increases StageBio's global scale and ability to serve multinational biopharma, medical device and academic researchers by adding a German laboratory facility and staff.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.